BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
ANTHERA PHARMA (NQ: ANTH)
0.5760 USD  +0.0060 (+1.05%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
(ANTH) Community Analysis from
June 18, 2013
Samuel Isaly’s OrbiMed Advisors manages around $5 Billion in healthcare related equities and venture capital. Eaton Vance Worldwide Health Sciences Fund managed to beat the S&P 500 index by more than 5 percentage points per year since Isaly took...
(Benzinga, 11/2/10)
Anthera Pharmaceuticals, Inc. (NasdaqANTH), today announced financial results and business highlights for the third quarter ended September 30, 2010. Financial Results Total operating expenses for the third quarter ended September...(read more)
(Benzinga, 9/23/10)
Shares of Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) are skyrocketing today, up more than 30% on strong volume. There is no news out on the stock that would cause the stock to have such a sharp runup, but it is being actively...(read more)
Anthera Pharmaceuticals (ANTH) Company Overview

There is no analysis for ANTH yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here